Comparative in vitro activity of Mk-0366 and other selected oral antimicrobial agents against Neisseria gonorrhoeae.
about
The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitroIn vitro and in vivo activity of DL-8280, a new oxazine derivativeIn vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasiiIn vitro antimicrobial sensitivity of Neisseria gonorrhoeae from RwandaNorfloxacin versus thiamphenicol for treatment of uncomplicated gonorrhea in Rwanda.Activities of new quinoline derivatives against genital pathogens.In vitro activities of the spectinomycin analog U-63366 and four quinolone derivatives against Neisseria gonorrhoeae.Norfloxacin in the therapy of uncomplicated gonorrhea.In vitro activity of A-56619 (difloxacin), A-56620, and other new quinolone antimicrobial agents against genital pathogens.In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogens.Pharmacokinetics of AT-2266 administered orally to mice, rats, dogs, and monkeys.Tentative interpretive standards for disk diffusion susceptibility testing with norfloxacin (MK-0366, AM-715)In vitro activities of ciprofloxacin, norfloxacin, pipemidic acid, cinoxacin, and nalidixic acid against Chlamydia trachomatisIn vitro antibacterial activity of norfloxacin (MK-0366).In vitro activity of MK-0366 against clinical urinary pathogens including gentamicin-resistant Pseudomonas aeruginosa.Determination of norfloxacin, a new nalidixic acid analog, in human serum and urine by high-performance liquid chromatography.Norfloxacin and silver norfloxacin in the treatment of Pseudomonas corneal ulcer in the rabbit.In vitro activity of norfloxacin, a quinolinecarboxylic acid, compared with that of beta-lactams, aminoglycosides, and trimethoprim.Antibacterial activity of norfloxacin.In vitro activity of norfloxacin against Chlamydia trachomatis.In vitro antibacterial activity of norfloxacin compared with eight other antimicrobial agents.
P2860
Q24670241-9E5B689D-158A-4901-9BB8-CECA30F9078DQ24674890-4C1FE84F-4C08-4FFB-AB96-B5DF199414E6Q28365998-32F90580-4F9A-47B5-8E87-5FC25A34E3FBQ33583207-26B1F265-5C63-4CD4-BAC0-9C525B0343E9Q35537803-3A83F9E4-6772-4715-9DCB-346569D7F9C0Q35568919-6AFB24A8-B4A6-4675-AABB-CD41CC21EB38Q35640288-509D33C3-0C6D-4944-ADF8-2948BA64851FQ35653365-67498595-2589-43FC-98D6-1B68A95893C4Q35653982-FBA6DAFF-615A-4B49-A568-945E45D2BD97Q35739778-C6B89668-81A4-449C-8D70-FC64CF939705Q35748588-58DF5EF6-1E0E-4D94-9317-163ADA6AFB14Q35769755-B047503F-3D2C-4CFB-A1DF-20A9EF410B7FQ37906392-509A0622-AFC4-4150-9A4E-BA55347DFBA0Q39856830-1B431368-324D-4A7E-A540-0C672FDEC6E3Q39856897-E9E0800C-BB89-4761-9FDF-09BA26146FC1Q39857099-DC113F4C-C11A-4DD7-B44E-6730D62EA2ECQ40087443-B5085CC6-3A85-4577-8BE2-D545D868967EQ41533055-F6097BDC-E160-4E5B-BF3C-7A92B39FBF04Q42928302-2C6B01E0-F0B4-45EC-9573-F2E514FCD4BBQ43442073-FE71E8DE-0A72-4D90-9B34-6AB5EAE42AECQ50211421-E76C7DB3-4DEF-4964-BAD8-9275DAA11558
P2860
Comparative in vitro activity of Mk-0366 and other selected oral antimicrobial agents against Neisseria gonorrhoeae.
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
1981年论文
@zh
1981年论文
@zh-cn
name
Comparative in vitro activity ...... against Neisseria gonorrhoeae.
@ast
Comparative in vitro activity ...... against Neisseria gonorrhoeae.
@en
type
label
Comparative in vitro activity ...... against Neisseria gonorrhoeae.
@ast
Comparative in vitro activity ...... against Neisseria gonorrhoeae.
@en
prefLabel
Comparative in vitro activity ...... against Neisseria gonorrhoeae.
@ast
Comparative in vitro activity ...... against Neisseria gonorrhoeae.
@en
P2093
P2860
P356
P1476
Comparative in vitro activity ...... against Neisseria gonorrhoeae.
@en
P2093
R P Gruninger
Y Siddiqui
P2860
P304
P356
10.1128/AAC.20.2.265
P407
P577
1981-08-01T00:00:00Z